Adam Dawson is a Managing Director in the Asset Management Division of Goldman Sachs, where he is responsible for equity investing in the healthcare and consumer sectors across EMEA. He joined Goldman Sachs in 2012 as an Associate, and became Managing Director in 2019. Mr. Dawson has represented Goldman Sachs on the Aragen Board since May 2021.
D S Brar is a life sciences industry veteran, with a career spanning over four decades. Prior to joining Aragen as Promoter-Chairman, Mr Brar led Ranbaxy...
Sanjay Reddy is the Founder-Vice Chairman of Aragen, and a successful entrepreneur with interests in energy, airports, transportation, real estate, and...
As a Promoter-Director at Aragen, Keshav Reddy leads board-mandated strategic projects in finance, M&A, branding, structuring and vision planning for...
Robert Ruffolo is a distinguished scientist, globally recognized for his executive leadership in the pharmaceutical industry. He served as the President...
After 32 years of service, Gerhard Mayr retired as the Executive Vice President, Pharmaceutical Operations at Eli Lilly and Company, in March 2004. At...
Rajat Sood is a Managing Director in the Asset Management Division at Goldman Sachs, focused on corporate and growth equity investing in India. Mr. Sood...
Adam Dawson is a Managing Director in the Asset Management Division of Goldman Sachs, where he is responsible for equity investing in the healthcare and...
Ajay Srivastava, has worked with Citibank in the area of Transactional Services and Corporate and Investment Banking for many years. Thereafter, he founded...
Anita Ramachandran heads Cerebrus Consultants and is a renowned Human Resource professional with deep knowledge and experience of over 40 years as a management...
Manni Kantipudi joined Aragen in 2007 as President. He is presently CEO and member of the Board of Directors, responsible for the overall growth, strategy,...
